Insider Buying: ReWalk Robotics Ltd. (NASDAQ:LFWD) Director Purchases 6,000 Shares of Stock

ReWalk Robotics Ltd. (NASDAQ:LFWD) Director Joseph E. Turk, Jr. purchased 6,000 shares of the company’s stock in a transaction on Friday, December 13th. The stock was acquired at an average price of $1.69 per share, with a total value of $10,140.00. Following the completion of the purchase, the director now directly owns 18,516 shares in the company, valued at $31,292.04. This trade represents a 47.94 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

ReWalk Robotics Price Performance

NASDAQ:LFWD opened at $1.50 on Thursday. The firm has a market capitalization of $13.21 million, a price-to-earnings ratio of -0.60 and a beta of 2.04. The business has a 50 day simple moving average of $2.16 and a 200-day simple moving average of $3.17. ReWalk Robotics Ltd. has a 1 year low of $1.45 and a 1 year high of $9.10.

ReWalk Robotics (NASDAQ:LFWD) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.08). ReWalk Robotics had a negative return on equity of 43.02% and a negative net margin of 77.21%. The firm had revenue of $6.13 million for the quarter, compared to analysts’ expectations of $8.38 million. During the same period in the previous year, the firm earned ($0.56) earnings per share. As a group, analysts expect that ReWalk Robotics Ltd. will post -1.78 earnings per share for the current fiscal year.

Hedge Funds Weigh In On ReWalk Robotics

An institutional investor recently bought a new position in ReWalk Robotics stock. Dimensional Fund Advisors LP bought a new stake in shares of ReWalk Robotics Ltd. (NASDAQ:LFWD) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned about 0.16% of ReWalk Robotics as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 26.76% of the company’s stock.

Analysts Set New Price Targets

Separately, HC Wainwright reiterated a “buy” rating and issued a $13.00 target price on shares of ReWalk Robotics in a research report on Wednesday, November 13th.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.